Chickasaw Capital Management’s AbbVie ABBV Stock Holding History

Chickasaw Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$209K	Hold	800	–	–	0.01%	94
2026 Q2	$201K	Buy	+800	New	+$172K	0.01%	97
2015 Q3	–	Sell	-12,800	Closed	-$860K	–	103
2015 Q2	$860K	Hold	12,800	–	–	0.03%	67
2015 Q1	$749K	Hold	12,800	–	–	0.02%	72
2014 Q4	$838K	Hold	12,800	–	–	0.03%	71
2014 Q3	$739K	Hold	12,800	–	–	0.02%	72
2014 Q2	$722K	Sell	12,800 -3,720	-23%	-$195K	0.03%	71
2014 Q1	$849K	Hold	16,520	–	–	0.04%	69
2013 Q4	$872K	Sell	16,520 -8,000	-33%	-$393K	0.05%	73
2013 Q3	$1.1M	Hold	24,520	–	–	0.07%	67
2013 Q2	$1.01M	Buy	+24,520	New	+$1.07M	0.08%	63

Other funds holding ABBV

HCM

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Chickasaw Capital Management's ABBV Position: Q3 2026 in Review

Chickasaw Capital Management held its AbbVie (ABBV) position steady in Q3 2026 at 800 shares worth $209K. The position accounts for 0.01% of the portfolio, ranked #94.

Chickasaw Capital Management first reported a position in ABBV in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.1M in Q3 2013. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Chickasaw Capital Management held 800 shares of AbbVie worth $209K as of Q3 2026.
Chickasaw Capital Management left its AbbVie share count unchanged in Q3 2026.
AbbVie made up 0.01% of Chickasaw Capital Management's portfolio in Q3 2026, its #94 holding.
Chickasaw Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 11 quarters since.
Chickasaw Capital Management's AbbVie position peaked at $1.1M in Q3 2013.
246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Chickasaw Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.